5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
5-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancers
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:367df1c239a3400ab814acaa85f4ccbc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:367df1c239a3400ab814acaa85f4ccbc2021-12-02T15:35:57Z5-Fluorouracil treatment induces characteristic T>G mutations in human cancer10.1038/s41467-019-12594-82041-1723https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc2019-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12594-8https://doaj.org/toc/2041-17235-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancersSharon ChristensenBastiaan Van der RoestNicolle BesselinkRoel JanssenSander BoymansJohn W. M. MartensMarie-Laure YaspoPeter PriestleyEwart KuijkEdwin CuppenArne Van HoeckNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-11 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Sharon Christensen Bastiaan Van der Roest Nicolle Besselink Roel Janssen Sander Boymans John W. M. Martens Marie-Laure Yaspo Peter Priestley Ewart Kuijk Edwin Cuppen Arne Van Hoeck 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
description |
5-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancers |
format |
article |
author |
Sharon Christensen Bastiaan Van der Roest Nicolle Besselink Roel Janssen Sander Boymans John W. M. Martens Marie-Laure Yaspo Peter Priestley Ewart Kuijk Edwin Cuppen Arne Van Hoeck |
author_facet |
Sharon Christensen Bastiaan Van der Roest Nicolle Besselink Roel Janssen Sander Boymans John W. M. Martens Marie-Laure Yaspo Peter Priestley Ewart Kuijk Edwin Cuppen Arne Van Hoeck |
author_sort |
Sharon Christensen |
title |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
title_short |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
title_full |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
title_fullStr |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
title_full_unstemmed |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
title_sort |
5-fluorouracil treatment induces characteristic t>g mutations in human cancer |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc |
work_keys_str_mv |
AT sharonchristensen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT bastiaanvanderroest 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT nicollebesselink 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT roeljanssen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT sanderboymans 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT johnwmmartens 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT marielaureyaspo 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT peterpriestley 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT ewartkuijk 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT edwincuppen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT arnevanhoeck 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer |
_version_ |
1718386404225974272 |